Regeneron Pharmaceuticals Inc. (REGN) Stock | Share Price | News

REGN · Health Care · United States United States

Regeneron Pharmaceuticals Inc. (REGN) is a company in the Health Care sector, based in United States. The stock is held in 22 ETFs we track – with its largest weight of 1.33 % in XUHC (msci-usa-health-care). That means you can hold Regeneron Pharmaceuticals indirectly and diversified through an ETF savings plan.

Very high ETF coverage: 22 of the 95 ETFs we cover hold Regeneron Pharmaceuticals, spread across 10 indices. That puts the stock in more ETFs than 90.0 % of the 4,369 stocks we cover.

Held in22 ETFs
Highest weight1.33 %
Indices10
SectorHealth Care
CountryUnited States
ISINUS75886F1075
WKN881535

Data note 1

Price chart

Data note 2

Performance

Performance
Year to date+2.3 %1 year+37.0 %
1 month+14.2 %3 months+29.2 %
Calendar year 2025+8.4 %
Calendar year 2026+2.9 %
52W

Data note 3

Risk metrics

Max drawdown-59.8 %
Volatility p.a.36.0 %
Best year2025: +8.4 %
Worst year2026: +2.9 %

Data note 4

Correlated with

The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.

Data note 5

Key financials

Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.

Revenue14.3 bn $
Net income4.5 bn $
Diluted EPS41.48 $
Net margin31.4 %
Return on equity14.4 %
Equity ratio77.1 %
Revenue growth+1.0 %
Revenue and profit by fiscal year
Fiscal yearRevenueNet incomeMargin
FY202313.14.030.1 %
FY202414.24.431.1 %
FY202514.34.531.4 %

Data note 6

Figures in USD bn. Source: SEC EDGAR (XBRL annual filings, public domain). US-listed SEC filers only.

Held in these ETFs

Data note 7

Want to know how much Regeneron Pharmaceuticals Inc. overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.

Stocks with similar ETF exposure

Names that reach a portfolio through largely the same funds as Regeneron Pharmaceuticals — the figure counts the ETFs holding both.

Data note 8

Latest Investment Intelligence News: Stocks